Other news to note for June 2, 2020

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Abbvie, Aerpio, Alligator, Anixa, Astrazeneca, Beigene, Biogen, Biotheus, Bold, Carna, Ceapro, Chimeron, Codiak, Daiichi Sankyo, Edigene, Eli Lilly, Emergent, Fujifilm, Heat Biologics, Hitgen, Hua Medicine, Humanigen, Immunitybio, Immunochina, Immutep, Innovation, Jacobio, Kalytera, Mateon, Merck, Moderna, Nantkwest, Novavax, Oncodesign, Ontochem, Organicell, Orpro, Oryzon Genomics, Oxford Biomedica, Praha Vaccines, Proteona, Proteostasis, Puretech, Rakuten Medical, Restorbio, Resverlogix, Seranovo, Shanghai Junshi, Shionogi, Synairgen, Takeda, Tetra, Tolero, Tonix, Toshiba, Twist, Vault, Vir, Virna.

Financings for June 2, 2020

Biopharmas in Asia-Pacific raising money in public or private financings, including: Genetic Technologies, Outlook, Pneumagen.

Regulatory front for June 2, 2020

The latest global regulatory news, changes and updates affecting biopharma, including: Blue Dog Coalition, FDA, U.S. House and Senate.

Clinical data for May 26-June 1, 2020

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Apellis, Atriva, Belx Bio-Pharmaceutical (Taiwan), Calcimedica, CTI Biopharma, Genentech, Gilead Sciences, Glenmark, I-Mab, Mesoblast, Moderna, Novavax, NS Pharma, Partner, Radius Health, Synairgen, Taiwan Liposome, Teijin, Transcenta, Zai Lab.

Regulatory actions for May 26-June 1, 2020

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Abivax, Accord Healthcare, Akeso, Algernon, Altimmune, Anivive Lifesciences, Astellas, Beyond Air, Cerecor, Diffusion, Hutchison China Meditech, Immunitybio, Longeveron, Moleculin, Opko Health, Orpheris, Phasebio, Qurient, Radius Health, Shanghai Henlius, Shionogi, Sino, Takeda, Teijin.

Conference data for May 29-June 1, 2020: ASCO

Data presented at the American Society of Clinical Oncology’s annual meeting.

No Comments